Decker, C J <br/><br/>
The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice.  [electronic resource] 

 -  Drugs under experimental and clinical research  2001 
 - 89-95 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0378-6501 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carbamates--chemistry<br/>Cells, Cultured<br/>Dose-Response Relationship, Drug<br/>Enzyme Inhibitors--chemistry<br/>Enzyme-Linked Immunosorbent Assay<br/>Graft Rejection--physiopathology<br/>Graft Survival--drug effects<br/>Graft vs Host Disease--drug therapy<br/>IMP Dehydrogenase--antagonists & inhibitors<br/>Immunosuppressive Agents--therapeutic use<br/>Interferon-gamma--blood<br/>Mice<br/>Mice, Inbred Strains<br/>Models, Animal<br/>Phenylurea Compounds--chemistry<br/>Skin--immunology<br/>Skin Transplantation--immunology<br/>Spleen--immunology